Changes in Nexstim Plc’s management Team, 9 March 2017

Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company aiming to improve rehabilitation for stroke patients with the use of non-invasive brain stimulation, announces that Petriina Puolakka will be stepping down from her role as Vice President, Legal Affairs and the member of the Management Team as of 7 April 2017 and will pursue opportunities outside the company.

NEXSTIM PLC

Martin Jamieson, Chairman and CEO

Further information

Nexstim
Martin Jamieson, Chairman and CEO
+447715163942
martin.jamiesonnexstimcom

UB Securities Oy (Certified Adviser)
+358 (0)9 2538 0246

Citigate Dewe Rogerson
Katja Stout
+44 (0)207 2821066
katja.stoutcitigatedr.couk

About Nexstim Plc

Nexstim is a medical technology company which has pioneered its technology in brain diagnostics with the Navigated Brain Stimulation (NBS) system as the first and only FDA-cleared and CE-marked navigated Transcranial Magnetic Stimulation (nTMS) system for pre-surgical mapping of the motor and speech cortices. Based on the same technology platform, the Company has developed a system called Navigated Brain Therapy (NBT®) which is CE-marked for chronic neuropathic pain, major depression and stroke therapy. Nexstim's shares are listed on Nasdaq First North Finland and Nasdaq First North Sweden. For more information please visit www.nexstim.com.